Our Research Mission

IVMT conducts world-leading research at the intersection of virology, metabolism, and therapeutic development. Our integrated approach combines cutting-edge computational methods with rigorous experimental validation to understand how viruses hijack host metabolism and to develop novel treatments.

Our research spans the full trajectory of viral disease—from acute infection through to post-viral syndromes like Long COVID and ME/CFS. By understanding the metabolic perturbations that viruses induce, we can identify new therapeutic targets and develop treatments that address both the infection itself and its long-term consequences.

Research Philosophy

We believe that transformative discoveries emerge at the boundaries between disciplines. IVMT integrates expertise in:

  • Virology — Understanding viral life cycles and pathogenesis
  • Metabolism — Mapping metabolic changes during and after infection
  • Computational Biology — AI-driven drug discovery and systems modeling
  • Clinical Science — Translating discoveries to patient benefit

Research Pillars

Three interconnected research streams driving innovation

Viral Metabolism & Pathogenesis

Understanding how viruses reprogram host cell metabolism to support their replication and spread, with focus on metabolic vulnerabilities as therapeutic targets.

  • Metabolic hijacking mechanisms
  • Host-virus metabolic interfaces
  • Antiviral target identification
Learn More

Computational Drug Discovery

Leveraging AI and machine learning for in silico drug design, virtual screening, and predictive modeling of drug-target interactions.

  • AI-driven drug design
  • Virtual screening pipelines
  • Molecular dynamics simulations
Learn More

Our Approach

01

Discovery

Basic research to understand viral-host metabolic interactions using multi-omics approaches, imaging, and systems biology.

02

Computation

AI-driven analysis of biological data and virtual screening to identify promising therapeutic candidates and targets.

03

Validation

Rigorous experimental testing of computational predictions using cell culture, organoids, and animal models.

04

Translation

Partnership with clinicians and industry to move validated discoveries toward clinical trials and patient benefit.

Interested in Our Research?

We welcome collaborations with researchers, clinicians, and industry partners who share our vision of transforming viral therapeutics.